Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.36% | -7.74% | -22.75% | -13.47% | 638.32% |
| Total Receivables | 13.79% | 491.21% | -52.26% | -14.99% | -19.06% |
| Inventory | 10.86% | -4.87% | -3.20% | 16.61% | -5.51% |
| Prepaid Expenses | -67.12% | -96.05% | 229.00% | 10.41% | 118.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.73% | -1.78% | -10.19% | -7.79% | 160.41% |
|
|
|||||
| Total Current Assets | -13.73% | -1.78% | -10.19% | -7.79% | 160.41% |
| Net Property, Plant & Equipment | -5.26% | -9.52% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.91% | -2.70% | -1.26% | 3.66% | -4.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.67% | -2.26% | -5.69% | -2.47% | 44.26% |
|
|
|||||
| Total Accounts Payable | -1.05% | -17.75% | 27.01% | 26.70% | 36.35% |
| Total Accrued Expenses | -- | -- | -- | -- | -64.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -4.54% | 36.73% | -7.39% | 4.21% | -3.37% |
| Total Other Current Liabilities | -4.54% | 36.73% | -7.39% | 4.21% | -3.37% |
| Total Current Liabilities | -2.94% | 5.04% | 9.92% | 13.17% | 8.77% |
|
|
|||||
| Total Current Liabilities | -2.94% | 5.04% | 9.92% | 13.17% | 8.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.94% | 5.04% | 9.92% | 13.17% | 8.77% |
|
|
|||||
| Common Stock & APIC | 3.89% | 2.14% | 0.91% | 7.31% | 13.17% |
| Retained Earnings | -7.04% | -3.99% | -5.47% | -13.72% | -11.56% |
| Treasury Stock & Other | 2.45% | -1.67% | 0.13% | 4.90% | 213.29% |
| Total Common Equity | -6.86% | -5.12% | -10.66% | -6.57% | 57.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.86% | -5.12% | -10.66% | -6.57% | 57.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.86% | -5.12% | -10.66% | -6.57% | 57.78% |
|
|
|||||